Hypochondroplasia
📧 Sign up to get email alerts when something new happens for Hypochondroplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia [Phase 2]
Open-label, long-term extension study of infigratinib in children with hypochondroplasia is currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia [Phase 3]
An ongoing long-term extension (Phase 3) study is evaluating Vosoritide in children with hypochondroplasia to assess long-term safety and ef…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of recombinant human growth hormone (Saizen) in children with hypochondroplasia treated fo…
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: C-Type Natriuretic Peptide and Achondroplasia
This update reports the completion of a clinical trial investigating C-type natriuretic peptide for achondroplasia and hypochondroplasia.